Cargando…

Is prognosis uniformly excellent in patients with stage II MSI-high colon cancer?

Detalles Bibliográficos
Autores principales:	Wang, Jane, Margonis, Georgios Antonios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577717/ https://www.ncbi.nlm.nih.gov/pubmed/36267788 http://dx.doi.org/10.21037/atm-22-3481

Ejemplares similares

Staged or Simultaneous Surgery for Colon or Rectal Cancer with Synchronous Liver Metastases: Implications for Study Design and Clinical Endpoints
por: Yaqub, Sheraz, et al.
Publicado: (2023)

High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
por: Mohamed, Amr, et al.
Publicado: (2021)

Gene Alterations, Mediators, and Artificial Intelligence in Colorectal Liver Metastases
por: Wagner, Doris, et al.
Publicado: (2022)

Explainable vs. interpretable artificial intelligence frameworks in oncology
por: Bertsimas, Dimitris, et al.
Publicado: (2023)

Prognostic and Therapeutic Implications of Tumor Biology in Colorectal Liver Metastases
por: Kamphues, Carsten, et al.
Publicado: (2021)

Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2017)

Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
por: Zhang, Qi, et al.
Publicado: (2023)

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2020)

Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer
por: Hu, Jing, et al.
Publicado: (2016)

Advanced In Situ TEM Microchip with Excellent Temperature Uniformity and High Spatial Resolution
por: Zhang, Xuelin, et al.
Publicado: (2023)

Precision surgery for colorectal liver metastases: Current knowledge and future perspectives
por: Margonis, Georgios Antonios, et al.
Publicado: (2022)

Complete response of MSI-high metastatic colon cancer following treatment with regorafenib: A case report
por: Baik, Hyungjoo, et al.
Publicado: (2021)

Addition of MPS-II to the Recommended Uniform Screening Panel in the United States
por: Millington, David S., et al.
Publicado: (2022)

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
por: Matevska-Geshkovska, Nadica, et al.
Publicado: (2018)

Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)

Is a Microsatellite Instability Still Useful for Tailored Treatment in Stage II and III Colon Cancer?
por: Kim, Nam Kyu
Publicado: (2014)

Uniformity in Reprints
Publicado: (1889)

Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer
por: Heregger, Ronald, et al.
Publicado: (2023)

Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
por: Yan, Wen-Yue, et al.
Publicado: (2016)

Wnt5a expression and prognosis in stage II–III colon cancer
por: Lund, Cecilia Margareta, et al.
Publicado: (2020)

The downregulation of NCXs is positively correlated with the prognosis of stage II–IV colon cancer
por: Xia, Zhixiu, et al.
Publicado: (2021)

K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy
por: Turaga, Kiran, et al.
Publicado: (2009)

Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies
por: He, Michelle Junyi, et al.
Publicado: (2022)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study
por: Lips, Daniel J, et al.
Publicado: (2011)

BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies
por: Wang, Pei-Pei, et al.
Publicado: (2022)

A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer
por: Ruan, Ji
Publicado: (2019)

Elderly High-Risk Stage II Colorectal Cancer Patients: Candidates for Improving Outcome?
por: Kim, Min Ki
Publicado: (2021)

Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer
por: Jee, Sun Hee, et al.
Publicado: (2011)

Celebrating excellence
por: Natarajan, Sundaram
Publicado: (2017)

An Excellent Appointment
Publicado: (1898)

An Excellent Appointment
Publicado: (1881)

An Excellent Appointment
Publicado: (1897)

An Excellent Selection
Publicado: (1897)

High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases
por: Gao, Mamie, et al.
Publicado: (2017)

Does Stage at Diagnosis Affect Prognosis of Patients With Stage IV Breast, Lung, and Colorectal Cancers?
por: Kiely, Belinda E
Publicado: (2018)

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
por: Zhang, Chunze, et al.
Publicado: (2022)

The Uniform Certificate—II
Publicado: (1908)

ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Baek, Moo-Jun
Publicado: (2015)

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer
por: Malinowsky, K, et al.
Publicado: (2014)

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
por: van Roon, Eddy HJ, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fnc11ocd199uql205kjdhg5r9a